Boryung Pharm (003850) — Cash Flow-to-Debt Ratio
Boryung Pharm (003850) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of ₩48.95 Billion could theoretically repay 0% of its total liabilities (₩537.67 Billion) in one year. See Boryung Pharm (003850) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Boryung Pharm Cash Flow-to-Debt Ratio (2009–2024)
Historical debt coverage capacity for Boryung Pharm across 13 annual periods. Also explore net asset momentum of Boryung Pharm to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Boryung Pharm (2009–2024)
Year-by-year debt coverage analysis for Boryung Pharm. For market capitalisation and broader financial context, see Boryung Pharm (003850) total market value.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | ₩80.56 Billion | ₩379.58 Billion | ▲ +84.1% |
| 2023 | 0.12x | ₩42.22 Billion | ₩366.26 Billion | ▲ +55.8% |
| 2022 | 0.07x | ₩27.81 Billion | ₩375.97 Billion | ▼ -56.4% |
| 2021 | 0.17x | ₩60.17 Billion | ₩354.33 Billion | ▲ +16.8% |
| 2020 | 0.15x | ₩44.74 Billion | ₩307.71 Billion | ▼ -30.5% |
| 2019 | 0.21x | ₩47.00 Billion | ₩224.68 Billion | ▲ +4.2% |
| 2018 | 0.20x | ₩38.91 Billion | ₩193.91 Billion | ▲ +224.6% |
| 2017 | -0.16x | ₩-24.61 Billion | ₩152.86 Billion | ▼ -448.3% |
| 2016 | 0.05x | ₩9.36 Billion | ₩202.55 Billion | ▼ -68.0% |
| 2012 | 0.14x | ₩18.38 Billion | ₩127.21 Billion | ▲ +95.7% |
| 2011 | 0.07x | ₩9.19 Billion | ₩124.42 Billion | ▼ -66.5% |
| 2010 | 0.22x | ₩24.12 Billion | ₩109.45 Billion | ▲ +223.6% |
| 2009 | 0.07x | ₩3.59 Billion | ₩52.77 Billion | — |